The renal and metabolic outcomes after sodium-glucose cotransporter 2 inhibitor in cardiac surgery – an open-label phase IV randomized controlled trial
Latest Information Update: 22 Oct 2021
At a glance
- Drugs Empagliflozin (Primary)
- Indications Acute kidney injury
- Focus Pharmacodynamics
- Acronyms The MERCURI trial
- 22 Oct 2021 New trial record